Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E6 protein is an oncoprotein encoded by the high-risk human papillomavirus type 16 (HPV16). It promotes cellular immortalization and plays a central role in cervical carcinogenesis and other HPV-associated malignancies by targeting key tumor suppressors like p53 and regulators such as hTERT. It contains two zinc finger domains and a C-terminal PDZ-binding motif.
Promotes p53 degradation via ubiquitin-dependent proteasomal pathway and E6AP recruitment; interacts with CBP/p300 to repress transcription; activates telomerase; disrupts cell polarity via PDZ domain interactions; enhances translation initiation complex assembly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 16 Oncoprotein E6 (None).